A detailed history of Xtx Topco LTD transactions in Regenxbio Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 13,177 shares of RGNX stock, worth $125,972. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,177
Previous 52,651 74.97%
Holding current value
$125,972
Previous $616,000 77.6%
% of portfolio
0.01%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.49 - $14.39 $414,082 - $568,030
-39,474 Reduced 74.97%
13,177 $138,000
Q2 2024

Aug 12, 2024

BUY
$11.51 - $21.53 $453,010 - $847,377
39,358 Added 296.08%
52,651 $616,000
Q1 2024

May 13, 2024

BUY
$12.17 - $24.61 $161,775 - $327,140
13,293 New
13,293 $280,000
Q3 2023

Nov 13, 2023

BUY
$16.46 - $19.99 $362,432 - $440,159
22,019 New
22,019 $362,000
Q2 2021

Aug 12, 2021

SELL
$32.46 - $40.48 $222,286 - $277,207
-6,848 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$33.61 - $49.95 $230,161 - $342,057
6,848 New
6,848 $234,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $413M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.